News

The agency assigned a PDUFA target action date of April 30, 2027.

Neel S. Vaidya, MD, MPH, MBA, on why keratoconus can progress aggressively in children and teens—and how early topographic screening and prompt crosslinking protect long-term vision.

Noha Ekdawi, MD, FAAP, explains why pediatric myopia demands individualized, progression-based management.

The company announced phase 2 results of a dual-action lifitegrast/perfluorohexyloctane dry eye drop alongside positive phase 1b results for BL1332, a first-in-class TRPV1 antagonist for ocular surface pain.

Teacher-led vision screening identified about 3 in 4 children with refractive error and correctly cleared most unaffected students.

The FDA has expanded the indication to include improvement of meibomian gland function in adult patients with evaporative dry eye disease due to MGD, making it the first treatment with this indication.

This review summarizes major contact lens risks, solution-related adverse effects, higher-risk populations, and practical prevention strategies for optometric practice.

Perceived stress modestly predicted later dry eye symptoms in young adults, but significance depended on a prespecified 1-tailed test.

Carolyn Majcher, OD, FAAO, discussed the impact of the FDA's approval of the drug for wet AMD after nearly 2 decades of off-label use.

Recommending omega-3 fatty acids in the diet of a patient with DED could lead to improved tear osmolarity and tear breakup time and thus fewer dry eye symptoms.

Phase 3 Duravyu insert misses key vision end point in wet AMD but cuts injections; pivotal LUCIA readout may decide its future.

Corrected presbyopes used larger fonts, held smartphones farther away, and read more slowly, suggesting 40-cm testing may miss device demands.

Katie W. Chu, OD, personalizes care towards her community by fostering proactive conversations with patients. She stopped by to discuss her recommendations for pediatric contact lens and LASIK consultation.

A maternal high-fat diet can negatively affect the retinal structure in mice.

Catch up on the top stories in optometry during the week of August 10-14.

The primary outcome of the trial is intraocular pressure (IOP) measured using Goldmann Applanation Tonometry (GAT).

A recent study examined the current state of readability in ophthalmic letters addressed to patients following their appointment and provides recommended solutions for improvement.

The WaveDȳn Vision Analyzer measures the eye's full optical error, and the WaveDȳn Advantage service uses those measurements to design a wavefront-guided scleral lens correcting both low- and higher-order aberrations.

Elkins shares the moving realities of volunteering with Remote Area Medical, from patients lining up before dawn to what it takes for an OD to get involved.

Myopia developed in 24.5% of initially nonmyopic male students over 3 years, with the highest risk among those with limited hyperopic reserve.

Leslie Scher, OD, focuses on identifying myopia and recommending treatment as soon as possible. Early intervention is shown to improve outcomes and prevent vision loss, and occurrence of severe ocular conditions.

Hamza Shah, OD, MS, FAAO, and Carolyn Majcher, OD, FAAO, weigh in on the recent FDA approval of the drug, which has been used off-label by compounding pharmacies for nearly 2 decades.

Contact lens technology has expanded beyond refractive error correction.

Catch up on the top stories in optometry during the week of August 3-7.

Steffen Schmitz-Valckenberg, MD, discusses how optical coherence tomography–based models may enable rapid, noninvasive assessment of functional loss in GA at Angiogenesis 2026.

Harrow will acquire Tyrvaya, the only FDA-approved nasal spray for dry eye disease, from Viatris for around $100 million, complementing its cyclosporine product Vevye.

Findings highlight the need for routine bilateral endothelial assessment in herpetic eye disease.

Myopia-control spectacle lenses reduce short-term progression in children by about 50%, though efficacy and long-term durability vary.